DTIL — PRECISION BIOSCIENCES INC

—
Nasdaq · Health Care · Biotechnology · CIK 1357874 ·
Last close
$7.05
Market Cap
$196.95M
52W High
$11.29
52W Low
$3.53
ADV30
383,053
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -20,428,000 -7,586,000 120,376,000 81,698,000 68,601,000
Jun 2026 0 — -19,161,000 -32,652,000 125,920,000 86,076,000 80,627,000
Mar 2026 10,838,000 — -9,075,000 -18,441,000 143,891,000 99,370,000 67,790,000
Dec 2025 34,204,000 — 12,508,000 20,133,000 154,416,000 110,823,000 62,168,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-51,761,000
Investing CF
$-638,000
Financing CF
$89,221,000
CapEx
$-704,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.24
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-586,867,000
Inventory
—
Receivables
$0
ST Investments
$148,000
EBIT TTM
$-38,165,000
Pretax Income TTM
$-39,431,000
Interest Exp TTM
$1,266,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$45,042,000
EBITDA
$-35,037,000
Free Cash Flow
$-18,004,750
Enterprise Value
$241,992,624
Total Cash
$81,846,000
Total Debt
$27,720,000
Shares Out
27,935,719
Trailing EPS
$0.25
Book Value
$1.86
ROE
-115.3%
ROA
-21.1%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 34,264,000 -52,148,000 -45,724,000 154,416,000 62,168,000 92,248,000 -65,843,000
Dec 2024 68,696,000 -26,162,000 7,167,000 136,388,000 79,995,000 56,393,000 -58,445,000
Dec 2023 48,727,000 -43,736,000 -61,319,000 159,781,000 140,920,000 18,861,000 -84,114,000
Dec 2022 25,098,000 -62,308,000 -111,637,000 238,169,000 177,736,000 60,433,000 -45,753,000

TTM Snapshot

Revenues TTM
$45,055,000
NetIncome TTM
$-52,732,000
OpCashFlow TTM
—
Assets (Latest)
$125,920,000
Forward EPS
$-1.86

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $7.50 · spot: $7.10 · call volume: 18 · put volume: 48
Expected Move to 2026-12-18: ±$2.37 (33.38%) — implied range $4.73 – $9.47 · ATM straddle on $7.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
IKT Inhibikase Therapeutics, Inc. $193.57M $1.38 —
CGEN COMPUGEN LTD $191.34M $2.02 —
ARTV Artiva Biotherapeutics, Inc. $190.81M $3.86 —
LCTX Lineage Cell Therapeutics, Inc. $206.36M $0.82 —
PALI PALISADE BIO, INC. $181.07M $1.01 —

News headlines (Yahoo Finance, 1h cache)

Precision BioSciences prices 10.24M shares at $7.75 in underwritten offering
2026-11-05 21:27 · Yahoo
Precision BioSciences Announces Pricing of $125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
2026-11-05 12:10 · Yahoo
Precision BioSciences Announces Late-Breaking PBGENE-HBV Data at AASLD The Liver Meeting® 2026 Further Demonstrating cccDNA Elimination and Potential to Drive Viral Cure
2026-11-05 12:00 · Yahoo
Precision BioSciences Announces Positive DSMB Safety Review Supporting Additional PBGENE-DMD Dosing in Phase 1/2 FUNCTION-DMD Study
2026-11-05 12:00 · Yahoo
Precision BioSciences: Q3 Earnings Snapshot
2026-11-03 12:11 · Yahoo
Precision BioSciences Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-03 12:01 · Yahoo
Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026
2026-10-29 11:01 · Yahoo
Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026
2026-10-08 11:01 · Yahoo
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
2026-08-24 10:01 · Yahoo
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-06 11:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.